The non-profit Institute for Clinical and Economic Review has issued a lukewarm final evidence report on Vertex ...

The FDA approves a new non-opioid pain pill, Journavx, to treat acute pain in adults. It's a first-generation non-addictive ...

FDA approval of a novel non-opioid analgesic will hopefully address the needs of many patients with acute pain and improve ...

Scientists have discovered a new mechanism that acts via an immune cell and points toward a different way of treating chronic ...

The study, which was published in the journal Pharmacological Reports, analyzed the impact of four terpenes that are found in ...

CHATHAM, NJ / ACCESS Newswire / March 31, 2025 / This post was written and published as a collaboration between the in-house ...

For patients with opioid use disorder (OUD), evidence supports continuation of buprenorphine during episodes of acute pain, ...

Dr. Frank Li was the sole owner of eight now-shuttered clinic locations of the Seattle Pain Centers. He recently moved into ...

We are excited to present four posters with important real-world data from our differentiated pain portfolio at PainConnect 2025 and are grateful to AAPM for selecting our poster at its meeting as a ...

Nurse-scientist hopes to empower primary care nurse practitioners to play a crucial role in improving access to ...

Ongoing shortages of opioid medicines are impacting palliative ... which is typically prescribed when other pain medications have not worked or cannot be tolerated. "It remains out of supply ...